Infliximab discontinuation in patients with ulcerative colitis

Lancet Gastroenterol Hepatol. 2021 Jun;6(6):412-413. doi: 10.1016/S2468-1253(21)00103-5. Epub 2021 Apr 20.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Colectomy
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / surgery
  • Humans
  • Infliximab / adverse effects

Substances

  • Antibodies, Monoclonal
  • Infliximab